VISTAGEN THERAPEUTICS INCORPORATED (VTGN)

Looking to buy VistaGen Therapeutics Stock? Get the latest VTGN quote, news, earnings, forecast, price targets, and market insights. Start investing on Public.com.

VistaGen Therapeutics (VTGN) Latest News & Updates – Why is it moving? What’s happening today? Get real-time market sentiment and stock updates

The latest VistaGen Therapeutics stock prices, stock quotes, news, and VTGN history to help you invest and trade smarter.

One user believes the stock is oversold and said they won’t panic-sell. Advertisement|Remove ads. VTGN stock has gained about 15% so far this year but has declined roughly 90% over the last 12 months.

Vistagen Therapeutics NASDAQ:VTGN said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage trial testing its ability to reduce symptoms in adults during a simulated public-speaking challenge, sending its shares down nearly 70% in premarket trading.The ...